MEACOR Inc.

About MEACOR Inc.

Meacor is a company focused on cardiovascular innovation, striving for healthier hearts by addressing serious medical conditions like mitral and tricuspid valve regurgitation. Their mission is to provide advanced, minimally invasive solutions to improve patient outcomes and quality of life, particularly for elderly patients with high surgical risks.

Products & Services

CryoCinch:A novel anchoring catheter system using on-demand cryoadhesion for beating heart procedures. It replicates the surgical annuloplasty standard of care without open-heart surgery, featuring a 15Fr catheter, cryo-anchoring technology, and a two-step reversible approach with minimal hardware.

Specialties

Cardiovascular Innovation Mitral and Tricuspid Valve Repair Minimally Invasive Procedures Cryo-Anchoring Technology Heart Valve Annuloplasty

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 15000000 MR: - FA: $15 million FAN: 15000000	D: 2024-05-14 FD: 2024-05-14	-

Series A Latest

2024-05-14

$15.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Toufic Azar

CEO/CTO

LinkedIn (Pro only)

R

Renzo Cecere

Chief Medical Officer

N

Nicolas Rouhana

General Manager of IM Capital

LinkedIn (Pro only)

N

Nadim Yared

Board Member

R

Rick Geoffrion

A

Azeem Latib

M.D.

View 5 more team members with Pro

Unlock Full Team Directory

Recent News

MEACOR Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised